APSR2026-1008

 
Late-Breaking
Submitted
Oral Presentation
AO34-005
 
 
https://storage.unitedwebnetwork.com/files/1285/1244897-46903-APSR-1008_439603.pptx
Format: PPTX Only
 
Format: PDF Only
08. Lung Cancer
9

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Muhammad Alfin Hanif * Faculty of Medicine, Universitas Indonesia Doctoral Programme in Biomedical Sciences Jakarta Indonesia Dharmais Cancer Hospital Thoracic Jakarta Indonesia
Fadillah - - Faculty of Medicine, Universitas Indonesia Doctoral Programme in Biomedical Sciences Jakarta Indonesia Faculty of Medicine, Universitas Indonesia Department of Medical Chemistry Jakarta Indonesia
Septelia Inawati Wanandi - Faculty of Medicine, Universitas Indonesia Doctoral Programme in Biomedical Sciences Jakarta Indonesia
Noorwati Sutandyo - Faculty of Medicine, Universitas Indonesia Doctoral Programme in Biomedical Sciences Jakarta Indonesia
Priscillia Imelda - Dharmais Cancer Hospital Thoracic Jakarta Indonesia Dharmais Cancer Hospital Clinical Research Unit Jakarta Indonesia
Harvey Romolo - Dharmais Cancer Hospital Thoracic Jakarta Indonesia
Reza Saputra - Dharmais Cancer Hospital Clinical Research Unit Jakarta Indonesia
Lyana Setiawan - Dharmais Cancer Hospital Clinical Research Unit Jakarta Indonesia
Arif Riswahyudi Hanafi - Dharmais Cancer Hospital Thoracic Jakarta Indonesia
 
 
 
 
 
 
Presenting Author Details
Muhammad
Alfin Hanif
malfinhanif@gmail.com
+6285310848600
41-50
Indonesia
Original Research
DNA Repair Gene Germline Variants in EGFR-Mutated Lung Adenocarcinoma with Absent Family History of Cancer
Maximum 25 words
Abstract Content
The contribution of hereditary cancer predisposition to lung adenocarcinoma remains incompletely understood. Current referral strategies for germline testing rely heavily on family history, potentially overlooking individuals with clinically significant inherited variants. Emerging evidence suggests that defects in DNA damage repair (DDR) pathways may contribute to lung carcinogenesis and interact with oncogenic driver mutations such as EGFR. This study aim to investigate the prevalence and spectrum of germline cancer-predisposition variants among EGFR-mutated lung adenocarcinoma patients.
In this cross-sectional observational study, patients with somatic EGFR-mutated lung adenocarcinoma treated at the National Cancer Centre Indonesia underwent germline testing using a hereditary cancer gene panel. Variants were classified according to established guidelines and categorized as pathogenic (P), likely pathogenic (LP), or variants of uncertain significance (VUS). Clinical and molecular characteristics were analyzed descriptively.
Among 80 patients, 9 (11.3%) had germline cancer-predisposition variants despite having no reported family history of cancer. Median age was 62 years (range 38–79); three were active smokers and two were passive smokers. Somatic EGFR alterations included exon 19 deletion (n=5), exon 21 L861Q (n=2), exon 21 L858R (n=1), and concurrent exon 20 T790M plus exon 21 L861Q (n=1). Germline variants were identified in ATM, BRCA1, BRCA2, FANCA, FANCD2, FH, RECQL4, and SLX4. Five patients carried P/LP variants in ATM, BRCA2, FANCA, FH, and SLX4 while four carried VUS in FANCD2, RECQL4, and BRCA1. Most affected genes were involved in homologous recombination and Fanconi anemia DNA repair pathways.
This study provides novel data from Indonesia on germline cancer-predisposition variants in EGFR-mutant lung adenocarcinoma, particularly involving DDR genes. The findings highlight limitations of family-history–based testing and support broader germline evaluation to improve inherited risk detection, inform genetic counseling and familial risk assessment, and identify patients who may benefit from targeted therapeutic strategies, including PARP inhibitor–based approaches.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Lung adenocarcinoma; EGFR mutation; Germline variants
maximum 3 keywords and no abbreviations, separated by commas
Doctoral Programme in Biomedical Sciences, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Dharmais Cancer Hospital, Jakarta, Indonesia
303